Point72 Asset Management
VIVO

Point72 Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Point72 Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-513,070
Closed -$5.01M – 1170
2019
Q4 		$5.01M Buy
+513,070
New +$4.82M 0.03% 498

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Asset Management's VIVO Position: Q1 2020 in Review

Point72 Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 513,070 shares — an estimated $5.01M sold.

Point72 Asset Management first reported a position in VIVO in Q4 2019 and held it in 1 quarter. The position peaked at $5.01M in Q4 2019. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

  • Point72 Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
  • Point72 Asset Management sold 513,070 Meridian Bioscience Inc shares in Q1 2020, an estimated $5.01M.
  • Point72 Asset Management first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 1 quarter.
  • Point72 Asset Management's Meridian Bioscience Inc position peaked at $5.01M in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.